AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$56.98
-1.06%
Mkt Cap $2.25B
Analyst Ratings
Buy
14
Hold
1
Sell
0
Price Target (28 analysts)
$73.88
Range $50.00 – $140.00
Implied Upside
+29.7%
Consensus $73.88 vs current $56.98
NASDAQ·Healthcare·Biotechnology
$56.98
-1.06%
Mkt Cap $2.25B
Buy
14
Hold
1
Sell
0
Price Target (28 analysts)
$73.88
Range $50.00 – $140.00
+29.7%
Consensus $73.88 vs current $56.98